Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01330030 · ClinicalTrials.gov registry record · Phase 2

Selegiline Patch for Treatment of Nicotine Dependence

A Phase 2 study of Tobacco Use Disorder, sponsored by Stanford University.

Completed
Registry status
Phase 2
Development phase
243
Enrollment target
1
Study location

NCT01330030: Completed Phase 2 study of Tobacco Use Disorder, sponsored by Stanford University.

NCT01330030 is a Phase 2 study of Tobacco Use Disorder that has completed, run by Stanford University. The registered enrollment target is 243 participants, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01330030, a Phase 2 study of Tobacco Use Disorder, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 2
Development phase
243 participants
Enrollment target
1
Study location

Study Summary

Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

Conditions Studied

Tobacco Use Disorder

Interventions

  • DRUG Selegiline
  • OTHER matching placebo

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 243 participants
Start Date 2005-07
Est. Completion 2011-07
Phase Phase 2

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01330030

The ClinicalTrials.gov registry entry for NCT01330030 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Selegiline is the first listed.

NCT01330030 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01330030 about?

NCT01330030 is a clinical study titled "Selegiline Patch for Treatment of Nicotine Dependence". Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.

What is the current status of trial NCT01330030?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 243 participants. The study started on 2005-07. Estimated completion is 2011-07.

What conditions does trial NCT01330030 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT01330030?

The interventions under investigation include: Selegiline (DRUG), matching placebo (OTHER).

Who is sponsoring clinical trial NCT01330030?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01330030 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.